loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Microlex e.U? Find 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide to address your drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 174Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 19Microlex e.U

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Microlex® MS-101

Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-101

Applications : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Microlex® MS-102

Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-102

Applications : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow
blank

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Microlex® MS-103

Excipient Details : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-103

Applications : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed
blank

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

09

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

10

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed
blank

11

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Microlex® HML C2910

Excipient Details : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...

Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.

Grade : Oral

arrow

Brand : MICROLEX® HML C2910

Applications : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/JPE

Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.

Grade : Oral

arrow
blank

12

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed
blank

14

arrow
Pharma, Lab & Chemical Expo
Not Confirmed